Autologous tumor cells/bacillus Calmette-Guérin/formalin-based novel breast cancer vaccine induces an immune antitumor response
Autologous tumor cells/bacillus Calmette-Guérin/formalin-based novel breast cancer vaccine induces an immune antitumor response |
https://doi.org/10.18632/oncotarget.25044
María José Godoy-Calderón,
Víctor Salazar,
Eglys González-Marcano,
and Ana Federica Convit
|
20222-20238 |
SAAV2152 is a single-stranded DNA binding protein: the third SSB in Staphylococcus aureus
SAAV2152 is a single-stranded DNA binding protein: the third SSB in Staphylococcus aureus |
https://doi.org/10.18632/oncotarget.24427
Yen-Hua Huang,
and Cheng-Yang Huang
|
20239-20254 |
Evaluation of the primitive fraction by functional in vitro assays at the RNA and DNA level represents a novel tool for complementing molecular monitoring in chronic myeloid leukemia
Evaluation of the primitive fraction by functional in vitro assays at the RNA and DNA level represents a novel tool for complementing molecular monitoring in chronic myeloid leukemia |
https://doi.org/10.18632/oncotarget.24749
María Sol Ruiz,
María Belén Sanchez,
Leandro Gutiérrez,
Daniel Koile,
Patricio Yankilevich,
Celeste Mosqueira,
Santiago Cranco,
María del Rosario Custidiano,
Josefina Freitas,
Cecilia Foncuberta,
Beatriz Moiraghi,
Carolina Pavlovsky,
Mariel Ana Pérez,
Verónica Ventriglia,
Julio Sanchez Ávalos,
José Mordoh,
Irene Larripa,
and Michele Bianchini
|
20255-20264 |
Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity
Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity |
https://doi.org/10.18632/oncotarget.24750
Angela McHugh,
Kenneth Fernandes,
Andrew P. South,
Jemima E. Mellerio,
Julio C. Salas-Alanís,
Charlotte M. Proby,
Irene M. Leigh,
and Mark K. Saville
|
20265-20281 |
The clinical impact of using complex molecular profiling strategies in routine oncology practice
The clinical impact of using complex molecular profiling strategies in routine oncology practice |
https://doi.org/10.18632/oncotarget.24757
Jean-François Laes,
Philippe Aftimos,
Philippe Barthelemy,
Joaquim Bellmunt,
Guy Berchem,
Carlos Camps,
Ramón de las Peñas,
Ana Finzel,
Jesús García-Foncillas,
Petteri Hervonen,
Ibrahim Wahid,
Timo Joensuu,
Louis Kathan,
Anthony Kong,
James Mackay,
Christos Mikropoulos,
Kefah Mokbel,
Jean-Loup Mouysset,
Sergey Odarchenko,
Timothy J. Perren,
Rika Pienaar,
Carlos Regonesi,
Shadi Salem Alkhayyat,
Abdul Rahman El Kinge,
Omalkhair Abulkhair,
Khaled Morsi Galal,
Hady Ghanem,
Fadi El Karak,
Angel Garcia,
Gregori Ghitti,
and Helen Sadik
|
20282-20293 |
Correlation of MDR1 gene polymorphism with propofol combined with remifentanil anesthesia in pediatric tonsillectomy
Correlation of MDR1 gene polymorphism with propofol combined with remifentanil anesthesia in pediatric tonsillectomy |
https://doi.org/10.18632/oncotarget.23168
YunLong Zhang,
Shuangfei Hu,
Hongfa Wang,
Fang Cai,
Sheliang Shen,
and Xiaopan Luo
|
20294-20303 |
TumorNext-Lynch-MMR: a comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair deficiency and Lynch syndrome
TumorNext-Lynch-MMR: a comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair deficiency and Lynch syndrome |
https://doi.org/10.18632/oncotarget.24854
Phillip N. Gray,
Pei Tsai,
Daniel Chen,
Sitao Wu,
Jayne Hoo,
Wenbo Mu,
Bing Li,
Huy Vuong,
Hsiao-Mei Lu,
Navanjot Batth,
Sara Willett,
Lisa Uyeda,
Swati Shah,
Chia-Ling Gau,
Monalyn Umali,
Carin Espenschied,
Mike Janicek,
Sandra Brown,
David Margileth,
Lavinia Dobrea,
Lawrence Wagman,
Huma Rana,
Michael J. Hall,
Theodora Ross,
Jonathan Terdiman,
Carey Cullinane,
Savita Ries,
Ellen Totten,
and Aaron M. Elliott
|
20304-20322 |
MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma |
https://doi.org/10.18632/oncotarget.24859
Saurabh Agarwal,
Giorgio Milazzo,
Kimal Rajapakshe,
Ronald Bernardi,
Zaowen Chen,
Eveline Barberi,
Jan Koster,
Giovanni Perini,
Cristian Coarfa,
and Jason M. Shohet
|
20323-20338 |
Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer
Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer |
https://doi.org/10.18632/oncotarget.24861
Gemma Bruera,
Silvia Massacese,
Antonio Galvano,
Antonella Dal Mas,
Stefano Guadagni,
Giuseppe Calvisi,
Eugenio Ciacco,
Antonio Russo,
Enrico Ricevuto,
and on behalf of Oncology Network ASL1 Abruzzo, Italy
|
20339-20350 |
Single-walled and multi-walled carbon nanotubes induce sequence-specific epigenetic alterations in 16 HBE cells
Single-walled and multi-walled carbon nanotubes induce sequence-specific epigenetic alterations in 16 HBE cells |
https://doi.org/10.18632/oncotarget.24866
Manosij Ghosh,
Deniz Öner,
Radu C. Duca,
Bram Bekaert,
Jeroen A.J. Vanoirbeek,
Lode Godderis,
and Peter H.M. Hoet
|
20351-20365 |
Regulatory effect of anti-gp130 functional mAb on IL-6 mediated RANKL and Wnt5a expression through JAK-STAT3 signaling pathway in FLS
Regulatory effect of anti-gp130 functional mAb on IL-6 mediated RANKL and Wnt5a expression through JAK-STAT3 signaling pathway in FLS |
https://doi.org/10.18632/oncotarget.23917
Ping Miao,
Xiao Wei Zhou,
Ping Wang,
Rong Zhao,
Ninan Chen,
Chao Ying Hu,
Xue Hua Chen,
Liu Qian,
Qi Wen Yu,
Ji Ying Zhang,
Rong Xu,
Dong Yi He,
Lian Bo Xiao,
Pu Li,
Mason Lu,
and Dong Qing Zhang
|
20366-20376 |
Combined linkage and association analysis of classical Hodgkin lymphoma
Combined linkage and association analysis of classical Hodgkin lymphoma |
https://doi.org/10.18632/oncotarget.24872
Alastair Lawrie,
Shuo Han,
Amit Sud,
Fay Hosking,
Timothee Cezard,
David Turner,
Caroline Clark,
Graeme I. Murray,
Dominic J. Culligan,
Richard S. Houlston,
and Mark A. Vickers
|
20377-20385 |
The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors
The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors |
https://doi.org/10.18632/oncotarget.24910
Eduardo C.A. Silva,
Flavio M. Cárcano,
Murilo Bonatelli,
Maurício G. Zaia,
Filipa Morais-Santos,
Fátima Baltazar,
Luiz F. Lopes,
Cristovam Scapulatempo-Neto,
and Céline Pinheiro
|
20386-20398 |
Measuring glucocorticoid receptor expression in vivo with PET
Measuring glucocorticoid receptor expression in vivo with PET |
https://doi.org/10.18632/oncotarget.24911
Charles Truillet,
Matthew F.L. Parker,
Loc T. Huynh,
Junnian Wei,
Khaled M. Jami,
Yung-Hua Wang,
Yuqin S. Shen,
Renuka Sriram,
David M. Wilson,
John Kurhanewicz,
and Michael J. Evans
|
20399-20408 |
Identification of copy number alterations in colon cancer from analysis of amplicon-based next generation sequencing data
Identification of copy number alterations in colon cancer from analysis of amplicon-based next generation sequencing data |
https://doi.org/10.18632/oncotarget.24912
Duarte Mendes Oliveira,
Gianluca Santamaria,
Carmelo Laudanna,
Simona Migliozzi,
Pietro Zoppoli,
Michael Quist,
Catie Grasso,
Chiara Mignogna,
Laura Elia,
Maria Concetta Faniello,
Cinzia Marinaro,
Rosario Sacco,
Francesco Corcione,
Giuseppe Viglietto,
Donatella Malanga,
and Antonia Rizzuto
|
20409-20425 |
Hotspot KRAS exon 2 mutations in CD166 positive colorectal cancer and colorectal adenoma cells
Hotspot KRAS exon 2 mutations in CD166 positive colorectal cancer and colorectal adenoma cells |
https://doi.org/10.18632/oncotarget.24921
Hung Lai Wong,
Lawrence Po Wah Ng,
Su Pin Koh,
Lawrence Wing Chi Chan,
Evelyn Yin Kwan Wong,
Vivian Weiwen Xue,
Hin Fung Andy Tsang,
Amanda Kit Ching Chan,
Ka Yue Chiu,
Wah Cheuk,
and Sze Chuen Cesar Wong
|
20426-20438 |
The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy
The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy |
https://doi.org/10.18632/oncotarget.24926
Ali Hosni,
Kathy Han,
Lisa W. Le,
Jolie Ringash,
James Brierley,
Rebecca Wong,
Robert Dinniwell,
Anthony Brade,
Laura A. Dawson,
Bernard J. Cummings,
Monika K. Krzyzanowska,
Eric X. Chen,
David Hedley,
Jennifer Knox,
Alexandra M. Easson,
Patricia Lindsay,
Tim Craig,
and John Kim
|
20439-20450 |
Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma
Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma |
https://doi.org/10.18632/oncotarget.24942
Steven F. Chen,
Zheng Liu,
Shyambabu Chaurasiya,
Thanh H. Dellinger,
Jianming Lu,
Xiwei Wu,
Hanjun Qin,
Jinhui Wang,
Yuman Fong,
and Yate-Ching Yuan
|
20451-20466 |
Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinoma
Increased level and fragmentation of plasma circulating cell-free DNA are diagnostic and prognostic markers for renal cell carcinoma |
https://doi.org/10.18632/oncotarget.24943
Yoshiyuki Yamamoto,
Motohide Uemura,
Kosuke Nakano,
Yujiro Hayashi,
Cong Wang,
Yu Ishizuya,
Toshiro Kinouchi,
Takuji Hayashi,
Kyosuke Matsuzaki,
Kentaro Jingushi,
Taigo Kato,
Atsunari Kawashima,
Takeshi Ujike,
Akira Nagahara,
Kazutoshi Fujita,
Ryoichi Imamura,
and Norio Nonomura
|
20467-20475 |
Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation
Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation |
https://doi.org/10.18632/oncotarget.24944
Karel Fostier,
Jo Caers,
Nathalie Meuleman,
Katrijn Broos,
Jurgen Corthals,
Kris Thielemans,
Rik Schots,
and Brenda De Keersmaecker
|
20476-20489 |
A set of cancer stem cell homing peptides associating with the glycan moieties of glycosphingolipids
A set of cancer stem cell homing peptides associating with the glycan moieties of glycosphingolipids |
https://doi.org/10.18632/oncotarget.24960
Yu-Hsiu Su,
Tai-Yun Lin,
Hung-Jen Liu,
and Chin-Kai Chuang
|
20490-20507 |
Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells
Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells |
https://doi.org/10.18632/oncotarget.24974
Kamil Lisek,
Elena Campaner,
Yari Ciani,
Dawid Walerych,
and Giannino Del Sal
|
20508-20523 |
A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer
A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer |
https://doi.org/10.18632/oncotarget.24980
Cleo Keppens,
Véronique Tack,
Nils ‘t Hart,
Lien Tembuyser,
Ales Ryska,
Patrick Pauwels,
Karen Zwaenepoel,
Ed Schuuring,
Florian Cabillic,
Luigi Tornillo,
Arne Warth,
Wilko Weichert,
and Elisabeth Dequeker for the EQA assessors expert group
|
20524-20538 |
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine |
https://doi.org/10.18632/oncotarget.24993
Pierpaolo Correale,
Cirino Botta,
Nicoletta Staropoli,
Valerio Nardone,
Pierpaolo Pastina,
Cristina Ulivieri,
Claudia Gandolfo,
Tatiana Cosima Baldari,
Stefano Lazzi,
Domenico Ciliberto,
Rocco Giannicola,
Antonella Fioravanti,
Antonio Giordano,
Silvia Zappavigna,
Michele Caraglia,
Pierfrancesco Tassone,
Luigi Pirtoli,
Maria Grazia Cusi,
and Pierosandro Tagliaferri
|
20539-20554 |
Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively
Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively |
https://doi.org/10.18632/oncotarget.24994
Amar S. Ahmad,
Vishnu Parameshwaran,
Luis Beltran,
Gabrielle Fisher,
Bernard V. North,
David Greenberg,
Geraldine Soosay,
Henrik Møller,
Peter Scardino,
Jack Cuzick,
and Daniel M. Berney on behalf of the Transatlantic Prostate Group
|
20555-20562 |
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma |
https://doi.org/10.18632/oncotarget.25003
Aurelia Lamanuzzi,
Ilaria Saltarella,
Vanessa Desantis,
Maria Antonia Frassanito,
Patrizia Leone,
Vito Racanelli,
Beatrice Nico,
Domenico Ribatti,
Paolo Ditonno,
Marcella Prete,
Antonio Giovanni Solimando,
Francesco Dammacco,
Angelo Vacca,
and Roberto Ria
|
20563-20577 |
Role of epigenetic factors in the selection of the alternative splicing isoforms of human KRAS in colorectal cancer cell lines
Role of epigenetic factors in the selection of the alternative splicing isoforms of human KRAS in colorectal cancer cell lines |
https://doi.org/10.18632/oncotarget.25016
Ángela L. Riffo-Campos,
Francisco Gimeno-Valiente,
Fernanda M. Rodríguez,
Andrés Cervantes,
Gerardo López-Rodas,
Luis Franco,
and Josefa Castillo
|
20578-20589 |
Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graft-versus-host disease: a multicenter prospective study
Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graft-versus-host disease: a multicenter prospective study |
https://doi.org/10.18632/oncotarget.25020
Sophie Servais,
Frédéric Baron,
Chantal Lechanteur,
Laurence Seidel,
Dominik Selleslag,
Johan Maertens,
Etienne Baudoux,
Pierre Zachee,
Michel Van Gelder,
Lucien Noens,
Tessa Kerre,
Philippe Lewalle,
Wilfried Schroyens,
Aurélie Ory,
and Yves Beguin
|
20590-20604 |
High incidence of other primary malignancies in patients with synchronous multiple gastric cancers “a multi-center retrospective cohort study”
High incidence of other primary malignancies in patients with synchronous multiple gastric cancers “a multi-center retrospective cohort study” |
https://doi.org/10.18632/oncotarget.25027
Daisuke Takeuchi,
Naohiko Koide,
Akira Suzuki,
Fumiaki Shimizu,
Yoshinori Koyama,
Takehito Ehara,
Yuta Yamamoto,
Makoto Koyama,
Satoshi Nakamura,
Masato Kitazawa,
Yusuke Miyagawa,
and Shinichi Miyagawa
|
20605-20616 |
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases
Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases |
https://doi.org/10.18632/oncotarget.25041
Leticia De Mattos-Arruda,
Charlotte K.Y. Ng,
Salvatore Piscuoglio,
Maria Gonzalez-Cao,
Raymond S. Lim,
Maria R. De Filippo,
Nicola Fusco,
Anne M. Schultheis,
Carolina Ortiz,
Santiago Viteri,
Alexandra Arias,
Gabriel S. Macedo,
Mafalda Oliveira,
Patricia Gomez,
Cristina Teixidó,
Paolo Nuciforo,
Vicente Peg,
Cristina Saura,
Santiago Ramon y Cajal,
Francesc Tresserra Casas,
Britta Weigelt,
Javier Cortes,
Joan Seoane,
and Jorge S. Reis-Filho
|
20617-20630 |
Sex-specific differences in the occurrence of Fusobacterium nucleatum subspecies and Fusobacterium periodonticum in the oral cavity
Sex-specific differences in the occurrence of Fusobacterium nucleatum subspecies and Fusobacterium periodonticum in the oral cavity |
https://doi.org/10.18632/oncotarget.25042
Karsten Henne,
Hildegard Schilling,
Mark Stoneking,
Georg Conrads,
and Hans-Peter Horz
|
20631-20639 |
Functional invadopodia formed in glioblastoma stem cells are important regulators of tumor angiogenesis
Functional invadopodia formed in glioblastoma stem cells are important regulators of tumor angiogenesis |
https://doi.org/10.18632/oncotarget.25045
Christos Petropoulos,
Pierre-Olivier Guichet,
Konstantin Masliantsev,
Michel Wager,
and Lucie Karayan-Tapon
|
20640-20657 |
microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes
microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes |
https://doi.org/10.18632/oncotarget.25057
Barbara Pardini,
Francesca Cordero,
Alessio Naccarati,
Clara Viberti,
Giovanni Birolo,
Marco Oderda,
Cornelia Di Gaetano,
Maddalena Arigoni,
Federica Martina,
Raffaele A. Calogero,
Carlotta Sacerdote,
Paolo Gontero,
Paolo Vineis,
and Giuseppe Matullo
|
20658-20669 |
COP9 signalosome subunit 5 regulates cancer metastasis by deubiquitinating SNAIL
COP9 signalosome subunit 5 regulates cancer metastasis by deubiquitinating SNAIL |
https://doi.org/10.18632/oncotarget.25060
Kensuke Watanabe,
Satoru Yokoyama,
Naoki Kaneto,
Takashi Hori,
Yusuke Iwakami,
Shinichiro Kato,
Yoshihiro Hayakawa,
Hiroaki Sakurai,
Junya Fukuoka,
and Ikuo Saiki
|
20670-20680 |
Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma
Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma |
https://doi.org/10.18632/oncotarget.25061
Tomas Garzon-Muvdi,
Debebe Theodros,
Andrew S. Luksik,
Russell Maxwell,
Eileen Kim,
Christopher M. Jackson,
Zineb Belcaid,
Sudipto Ganguly,
Betty Tyler,
Henry Brem,
Drew M. Pardoll,
and Michael Lim
|
20681-20697 |
Evaluation of the impact of S-adenosylmethionine-dependent methyltransferase inhibitor, 3-deazaneplanocin A, on tissue injury and cognitive function in mice
Evaluation of the impact of S-adenosylmethionine-dependent methyltransferase inhibitor, 3-deazaneplanocin A, on tissue injury and cognitive function in mice |
https://doi.org/10.18632/oncotarget.25062
Eva Lhuissier,
Juliette Aury-Landas,
Valentine Bouet,
Céline Bazille,
Yohann Repesse,
Thomas Freret,
Karim Boumédiene,
and Catherine Baugé
|
20698-20708 |
Increased mucosal expression of miR-215 precedes the development of neoplasia in patients with long-standing ulcerative colitis
Increased mucosal expression of miR-215 precedes the development of neoplasia in patients with long-standing ulcerative colitis |
https://doi.org/10.18632/oncotarget.25065
Joel Pekow,
Katherine Meckel,
Urszula Dougherty,
Haider I. Haider,
Zifeng Deng,
John Hart,
David T. Rubin,
and Marc Bissonnette
|
20709-20720 |
Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion
Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion |
https://doi.org/10.18632/oncotarget.25067
Lucia Anna Muscarella,
Daniela Turchetti,
Andrea Fontana,
Filomena Baorda,
Orazio Palumbo,
Annamaria la Torre,
Danilo de Martino,
Renato Franco,
Nunzia Simona Losito,
Andrea Repaci,
Uberto Pagotto,
Luigia Cinque,
Massimiliano Copetti,
Maria Grazia Chiofalo,
Luciano Pezzullo,
Paolo Graziano,
Alfredo Scillitani,
and Vito Guarnieri
|
20721-20733 |
Selected PET radiomic features remain the same
Selected PET radiomic features remain the same |
https://doi.org/10.18632/oncotarget.25070
Tetsuya Tsujikawa,
Hideaki Tsuyoshi,
Masafumi Kanno,
Shizuka Yamada,
Masato Kobayashi,
Norihiko Narita,
Hirohiko Kimura,
Shigeharu Fujieda,
Yoshio Yoshida,
and Hidehiko Okazawa
|
20734-20746 |
Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy
Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy |
https://doi.org/10.18632/oncotarget.25087
Bushra Weidenbusch,
Günther H.S. Richter,
Marie Sophie Kesper,
Monika Guggemoos,
Katja Gall,
Carolin Prexler,
Ilya Kazantsev,
Alexandra Sipol,
Lars Lindner,
Michaela Nathrath,
Olaf Witt,
Katja Specht,
Frigga Beitinger,
Carolin Knebel,
Stuart Hosie,
Rüdiger von Eisenhardt-Rothe,
Wilko Weichert,
Irene Teichert-von Luettichau,
and Stefan Burdach
|
20747-20760 |
Clinical application of targeted next-generation sequencing for colorectal cancer patients: a multicentric Belgian experience
Clinical application of targeted next-generation sequencing for colorectal cancer patients: a multicentric Belgian experience |
https://doi.org/10.18632/oncotarget.25099
Nicky D’Haene,
Quitterie Fontanges,
Nancy De Nève,
Oriane Blanchard,
Barbara Melendez,
Monique Delos,
Marie-Françoise Dehou,
Calliope Maris,
Nathalie Nagy,
Emmanuel Rousseau,
Josse Vandenhove,
André Gilles,
Carine De Prez,
Laurine Verset,
Marie-Paule Van Craynest,
Pieter Demetter,
Jean-Luc Van Laethem,
Isabelle Salmon,
and Marie Le Mercier
|
20761-20768 |
Four immunohistochemical assays to measure the PD-L1 expression in malignant pleural mesothelioma
Four immunohistochemical assays to measure the PD-L1 expression in malignant pleural mesothelioma |
https://doi.org/10.18632/oncotarget.25100
Takuya Watanabe,
Katsuhiro Okuda,
Takayuki Murase,
Satoru Moriyama,
Hiroshi Haneda,
Osamu Kawano,
Keisuke Yokota,
Tadashi Sakane,
Risa Oda,
Hiroshi Inagaki,
and Ryoichi Nakanishi
|
20769-20780 |
A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy
A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy |
https://doi.org/10.18632/oncotarget.25111
Dina Mönch,
Sabine Bode-Erdmann,
Jörg Kalla,
Jörn Sträter,
Carsten Schwänen,
Roger Falkenstern-Ge,
Siegfried Klumpp,
Godehard Friedel,
German Ott,
and Claudia Kalla
|
20781-20794 |
Prognostic value of LINE-1 methylation level in 321 patients with primary liver cancer including hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Prognostic value of LINE-1 methylation level in 321 patients with primary liver cancer including hepatocellular carcinoma and intrahepatic cholangiocarcinoma |
https://doi.org/10.18632/oncotarget.25124
Tatsunori Miyata,
Yo-Ichi Yamashita,
Yoshifumi Baba,
Kazuto Harada,
Takanobu Yamao,
Naoki Umezaki,
Masayo Tsukamoto,
Yuki Kitano,
Kensuke Yamamura,
Kota Arima,
Shigeki Nakagawa,
Hirohisa Okabe,
Katsunori Imai,
Daisuke Hashimoto,
Akira Chikamoto,
Mototsugu Shimokawa,
and Hideo Baba
|
20795-20806 |
Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies
Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies |
https://doi.org/10.18632/oncotarget.24829
Massimiliano Berretta,
Agnieszka Micek,
Alessandra Lafranconi,
Sabrina Rossetti,
Raffaele Di Francia,
Paolo De Paoli,
Paola Rossi,
and Gaetano Facchini
|
20807-20815 |
Defunctioning ileostomy reduces leakage rate in rectal cancer surgery - systematic review and meta-analysis
Defunctioning ileostomy reduces leakage rate in rectal cancer surgery - systematic review and meta-analysis |
https://doi.org/10.18632/oncotarget.25015
Magdalena Pisarska,
Natalia Gajewska,
Piotr Małczak,
Michał Wysocki,
Jan Witowski,
Grzegorz Torbicz,
Piotr Major,
Magdalena Mizera,
Marcin Dembiński,
Marcin Migaczewski,
Andrzej Budzyński,
and Michał Pędziwiatr
|
20816-20825 |
Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity
Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity |
https://doi.org/10.18632/oncotarget.24846
Marco Tucci,
Francesco Mannavola,
Anna Passarelli,
Luigia Stefania Stucci,
Mauro Cives,
and Franco Silvestris
|
20826-20837 |
The versatile nature of miR-9/9* in human cancer
The versatile nature of miR-9/9* in human cancer |
https://doi.org/10.18632/oncotarget.24889
Katarzyna Nowek,
Erik A.C. Wiemer,
and Mojca Jongen-Lavrencic
|
20838-20854 |
Hypertension in malignancy–an underappreciated problem
Hypertension in malignancy–an underappreciated problem |
https://doi.org/10.18632/oncotarget.25024
Jolanta Małyszko,
Maciej Małyszko,
Leszek Kozlowski,
Klaudia Kozlowska,
and Jacek Małyszko
|
20855-20871 |
The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer
The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer |
https://doi.org/10.18632/oncotarget.25038
Cristian Arriaga-Canon,
Inti Alberto De La Rosa-Velázquez,
Rodrigo González-Barrios,
Rogelio Montiel-Manríquez,
Diego Oliva-Rico,
Francisco Jiménez-Trejo,
Carlo Cortés-González,
and Luis A. Herrera
|
20872-20890 |
Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives
Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives |
https://doi.org/10.18632/oncotarget.25058
Stanislaw Schmidt,
Lars Tramsen,
Bushra Rais,
Evelyn Ullrich,
and Thomas Lehrnbecher
|
20891-20907 |
Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages
Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages |
https://doi.org/10.18632/oncotarget.24556
Amber E. de Groot,
and Kenneth J. Pienta
|
20908-20927 |
Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations
Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations |
https://doi.org/10.18632/oncotarget.25037
Richard Greil,
Lisa Pleyer,
Bettina Jansko,
Carmen Feierabend,
Lukas Rettenbacher,
Olga Stiefel,
Christoph Rass,
Patrick Morre,
Daniel Neureiter,
and Sigrun Greil-Ressler
|
20928-20940 |